vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $140.7M, roughly 1.7× Purple Innovation, Inc.). Purple Innovation, Inc. runs the higher net margin — -2.3% vs -35.0%, a 32.7% gap on every dollar of revenue. On growth, Purple Innovation, Inc. posted the faster year-over-year revenue change (9.1% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $-7.8M). Over the past eight quarters, Purple Innovation, Inc.'s revenue compounded faster (8.3% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”
CCRN vs PRPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $140.7M |
| Net Profit | $-82.9M | $-3.2M |
| Gross Margin | — | 41.9% |
| Operating Margin | -30.2% | -1.6% |
| Net Margin | -35.0% | -2.3% |
| Revenue YoY | -23.6% | 9.1% |
| Net Profit YoY | -2109.7% | 62.1% |
| EPS (diluted) | $-2.56 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $140.7M | ||
| Q3 25 | $250.1M | $118.8M | ||
| Q2 25 | $274.1M | $105.1M | ||
| Q1 25 | $293.4M | $104.2M | ||
| Q4 24 | $309.9M | $129.0M | ||
| Q3 24 | $315.1M | $118.6M | ||
| Q2 24 | $339.8M | $120.3M | ||
| Q1 24 | $379.2M | $120.0M |
| Q4 25 | $-82.9M | $-3.2M | ||
| Q3 25 | $-4.8M | $-11.7M | ||
| Q2 25 | $-6.7M | $-17.3M | ||
| Q1 25 | $-490.0K | $-19.1M | ||
| Q4 24 | $-3.8M | $-8.5M | ||
| Q3 24 | $2.6M | $-39.2M | ||
| Q2 24 | $-16.1M | $27.0K | ||
| Q1 24 | $2.7M | $-50.2M |
| Q4 25 | — | 41.9% | ||
| Q3 25 | 20.4% | 42.8% | ||
| Q2 25 | 20.4% | 35.9% | ||
| Q1 25 | 20.0% | 39.4% | ||
| Q4 24 | — | 42.9% | ||
| Q3 24 | 20.4% | 29.7% | ||
| Q2 24 | 20.8% | 40.7% | ||
| Q1 24 | 20.4% | 34.8% |
| Q4 25 | -30.2% | -1.6% | ||
| Q3 25 | -2.4% | -10.2% | ||
| Q2 25 | -2.1% | -13.5% | ||
| Q1 25 | -0.3% | -13.9% | ||
| Q4 24 | -1.1% | -6.0% | ||
| Q3 24 | 0.9% | -39.5% | ||
| Q2 24 | -5.7% | -12.1% | ||
| Q1 24 | 0.8% | -19.3% |
| Q4 25 | -35.0% | -2.3% | ||
| Q3 25 | -1.9% | -9.9% | ||
| Q2 25 | -2.4% | -16.5% | ||
| Q1 25 | -0.2% | -18.4% | ||
| Q4 24 | -1.2% | -6.6% | ||
| Q3 24 | 0.8% | -33.1% | ||
| Q2 24 | -4.7% | 0.0% | ||
| Q1 24 | 0.7% | -41.8% |
| Q4 25 | $-2.56 | $0.03 | ||
| Q3 25 | $-0.15 | $0.11 | ||
| Q2 25 | $-0.20 | $0.16 | ||
| Q1 25 | $-0.02 | $0.18 | ||
| Q4 24 | $-0.13 | $0.08 | ||
| Q3 24 | $0.08 | $0.36 | ||
| Q2 24 | $-0.47 | $0.00 | ||
| Q1 24 | $0.08 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $24.3M |
| Total DebtLower is stronger | — | $126.7M |
| Stockholders' EquityBook value | $322.8M | $-29.7M |
| Total Assets | $449.0M | $296.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $24.3M | ||
| Q3 25 | $99.1M | $32.4M | ||
| Q2 25 | $81.2M | $34.2M | ||
| Q1 25 | $80.7M | $21.6M | ||
| Q4 24 | $81.6M | $29.0M | ||
| Q3 24 | $64.0M | $23.4M | ||
| Q2 24 | $69.6M | $23.4M | ||
| Q1 24 | $5.2M | $34.5M |
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $322.8M | $-29.7M | ||
| Q3 25 | $408.1M | $-26.9M | ||
| Q2 25 | $412.2M | $-15.6M | ||
| Q1 25 | $418.2M | $1.3M | ||
| Q4 24 | $419.0M | $20.2M | ||
| Q3 24 | $424.7M | $28.0M | ||
| Q2 24 | $433.3M | $66.4M | ||
| Q1 24 | $462.4M | $65.5M |
| Q4 25 | $449.0M | $296.3M | ||
| Q3 25 | $538.2M | $302.1M | ||
| Q2 25 | $553.8M | $303.8M | ||
| Q1 25 | $576.2M | $293.8M | ||
| Q4 24 | $589.3M | $307.8M | ||
| Q3 24 | $597.4M | $309.3M | ||
| Q2 24 | $602.9M | $362.1M | ||
| Q1 24 | $648.4M | $382.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $-5.8M |
| Free Cash FlowOCF − Capex | $16.1M | $-7.8M |
| FCF MarginFCF / Revenue | 6.8% | -5.5% |
| Capex IntensityCapex / Revenue | 0.9% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $-41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $-5.8M | ||
| Q3 25 | $20.1M | $-968.0K | ||
| Q2 25 | $4.2M | $-4.0M | ||
| Q1 25 | $5.7M | $-23.1M | ||
| Q4 24 | $24.2M | $6.8M | ||
| Q3 24 | $7.5M | $1.1M | ||
| Q2 24 | $82.4M | $-8.9M | ||
| Q1 24 | $6.0M | $-16.8M |
| Q4 25 | $16.1M | $-7.8M | ||
| Q3 25 | $17.9M | $-1.8M | ||
| Q2 25 | $2.3M | $-7.0M | ||
| Q1 25 | $3.8M | $-25.3M | ||
| Q4 24 | $21.7M | $5.7M | ||
| Q3 24 | $6.3M | $101.0K | ||
| Q2 24 | $79.6M | $-11.0M | ||
| Q1 24 | $3.8M | $-19.9M |
| Q4 25 | 6.8% | -5.5% | ||
| Q3 25 | 7.2% | -1.5% | ||
| Q2 25 | 0.8% | -6.6% | ||
| Q1 25 | 1.3% | -24.3% | ||
| Q4 24 | 7.0% | 4.4% | ||
| Q3 24 | 2.0% | 0.1% | ||
| Q2 24 | 23.4% | -9.2% | ||
| Q1 24 | 1.0% | -16.5% |
| Q4 25 | 0.9% | 1.4% | ||
| Q3 25 | 0.9% | 0.7% | ||
| Q2 25 | 0.7% | 2.8% | ||
| Q1 25 | 0.6% | 2.2% | ||
| Q4 24 | 0.8% | 0.8% | ||
| Q3 24 | 0.4% | 0.9% | ||
| Q2 24 | 0.8% | 1.7% | ||
| Q1 24 | 0.6% | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
